Frontier Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Frontier Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,078	Closed	-$566K	–	374
2019 Q1	$566K	Hold	3,078	–	–	0.08%	203
2018 Q4	$510K	Hold	3,078	–	–	0.08%	201
2018 Q3	$593K	Sell	3,078 -1,000	-25%	-$178K	0.06%	205
2018 Q2	$693K	Hold	4,078	–	–	0.1%	175
2018 Q1	$665K	Sell	4,078 -1,000	-20%	-$163K	0.09%	187
2017 Q4	$761K	Hold	5,078	–	–	0.12%	158
2017 Q3	$772K	Sell	5,078 -1,000	-16%	-$151K	0.11%	173
2017 Q2	$783K	Hold	6,078	–	–	0.12%	173
2017 Q1	$665K	Hold	6,078	–	–	0.1%	190
2016 Q4	$448K	Buy	+6,078	New	+$495K	0.07%	231

Other funds holding VRTX

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return